Glucagon-like peptide-1 receptor agonists mitigate the risk of major adverse cardiovascular events in patients with atopic dermatitis and type 2 diabetes
收藏Mendeley Data2026-04-09 收录
下载链接:
https://data.mendeley.com/datasets/8b97vdk8ts/1
下载链接
链接失效反馈官方服务:
资源简介:
Supplementary materials for a study examining the impact of glucagon-like peptide-1 receptor agonists (GLP-1RAs) on cardiovascular outcomes in patients with atopic dermatitis.



